Overview of Japanese Generic Drug Market 2016: Recent Volume Share was 60.1% in the 2nd Quarter in 2016

Thursday, October 20, 2016 9:02 AM UTC

Dublin, Oct. 20, 2016 -- Research and Markets has announced the addition of the "The Overview of Japanese Generic Drug Market" report to their offering.

This report talks about the overview of Japanese generic drug market.

The readers will understand overall climate surrounding generic market in Japan. The report covers related regulations, generics's share in Japan, market size, primary makers, market trend, and updated situation about biosimilars and authorized generics.

The share of generics in the prescription drugs market has been dramatically increasing in terms of both volume and value. The recent volume share was 60.1% in the 2nd quarter in 2016. This increase has been particularly pronounced since 2007 due to government measures devised to increase the use of generics.

Key Topics Covered:

1. Summary

2. Definition of Generic Drugs

3. Laws and Regulations Pertaining to Generics

4. NHI Drug Price

5. Share of Generics in Prescription Drugs Market

6. Market Size

7. Principal Industry Association

8. Sales of Major Japanese Generic Companies

9. Primary Generic Manufacturers

10. Overview of Leading Japanese Generics Companies

11. Current Market Environment Conditions

12. Considerations by Company Type

13. Government Measures to Promote the Use of Generics

14. Biosimilars

15. Authorized Generics

16. Future Outlook

Companies Mentioned

Actavis
Boehringer Ingelheim
Daiichi Sankyo
Hospira
Lupin
Meiji
Mochida
Mylan
Nichi-Iko
Nippon Chemiphar
Nippon Kayaku,Kissei
Ohara
Sandoz
Sanwa
Sawai
Teva
Towa
Zydus

For more information about this report visit http://www.researchandmarkets.com/research/fpctz5/the_overview_of



CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Generic Drugs

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Overview of Japanese Generic Drug Market 2016: Recent Volume Share was 60.1% in the 2nd Quarter in 2016

Editor's Picks

Welcome to EconoTimes